今日观察！虚幻之城，歌声起航！元宇宙虚拟演唱会《元素之城》第一部11月震撼登场

虚幻之城，歌声起航！元宇宙虚拟演唱会《元素之城》第一部11月震撼登场

北京 - 2024年6月14日 - 由星鱼科技携大湾区卫视、广东电视台音乐之声联合主办的元宇宙虚拟演唱会《元素之城》第一部，将于11月震撼登场。这场史诗级虚拟盛宴，将带领观众穿越星际，感受未来世界的神奇魅力，体验前所未有的视听享受。

《元素之城》虚拟演唱会，以科幻、魔幻、二次元、虚拟现实等多元素融合，讲述了未来星际中，一众音乐使者为拯救濒危的地球，踏上收集能量宝石的征途，并通过音乐和歌声传递希望与力量的故事。

演唱会将采用最先进的虚拟技术，打造六大风格迥异的未来星球舞台，并邀请众多知名虚拟艺人参与演出。观众们将化身星际探索者，跟随音乐使者的脚步，穿梭于各个星球之间，感受不同星球的独特魅力，并沉浸在美妙的音乐之中。

据了解，《元素之城》虚拟演唱会耗时五年精心打造，在技术上实现了多项创新突破，为观众带来更加逼真、震撼的视听体验。演唱会将采用实时渲染、高精建模、数实融合、全景交互等技术，打造出一个充满想象力的未来世界。

届时，观众们将可以在抖音等多个平台观看演唱会直播。同时，演唱会还将推出多款周边产品，让观众们可以将虚拟世界的精彩带入现实生活。

《元素之城》虚拟演唱会的举办，标志着我国虚拟演唱会技术发展迈入了新阶段，也为观众们带来了全新的娱乐体验。这场跨越时空的音乐盛宴，将带领观众们开启一场奇妙的星际冒险之旅，感受未来世界的无限可能。

期待已久的观众们，请准备好迎接这场震撼心灵的视听盛宴吧！

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.